Unravel Health
PrivateLast Round
Pre Seed
Oct 14, 2026
Total Funding Raised
$3.46M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Unravel Health operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Pre Seed round in October 2026.
Unravel Health is a health technology company that develops a non-invasive, at-home saliva monitoring device to track hormonal patterns and biomarkers for women's health.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Health IoT, Precision Medicine
Business Model
B2C
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Unravel Health Comparables
Compare Unravel Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hormona | 84% | |
| Eli Health | 84% | |
| Mint Diagnostics | 79% |
For institutional investors. Book with your work email.
Unravel Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Oct 14, 2026 | ||||
| Grant | Feb 20, 2025 | ||||
| Accelerator | Dec 3, 2024 | ||||
| Accelerator | Oct 25, 2024 |
For institutional investors. Book with your work email.
Unravel Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| STAC | Accelerator |
| Zinc | Pre Seed |
| Ascension Ventures | Pre Seed |
| Leo Capital | Pre Seed |
| University of Glasgow | Accelerator |
| SBRI Healthcare | Grant |
| Health Innovation Network | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2026
$3.3M round led by Ascension Ventures
- Jul 25, 2026
Monthly visitors increased 60% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 22, 2026
Unravel receives $2.8M in financing to launch its Micro Lab for at-home, saliva-based hormone testing and daily health insights.
- is_developingOct 19, 2026
Unravel is developing the Micro Lab, which reads multiple hormones from an at-home saliva sample in minutes to bridge the gap between blood tests and wearable estimates; the London-based company raises £2.5 million to advance the device in United Kingdom in Oct '26.
- is_developingOct 19, 2026
Unravel raises £2.5 million to develop the Micro Lab, a palm-sized device designed to read multiple hormones from a saliva sample at home in minutes, in the United Kingdom.
- receives_financingOct 19, 2026
Unravel receives $3.32M in Pre Seed financing in the United Kingdom on Oct 16th '26, led by Conduit EIS Impact Fund and Wrightwood with participation from Leo Capital, Embryo Ventures, Hermesa and Zinc VC, to develop its palm-sized hormone-testing device.
For institutional investors. Book with your work email.
Unravel Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Unravel Health's valuation, stock price, and market status.
Is Unravel Health a public or private company?
Unravel Health is a private company.
What is the current stock price of Unravel Health?
Unravel Health is a private company, so its shares have no public market price. Caplight tracks Unravel Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Unravel Health worth (valuation)?
Valuation information for Unravel Health is not publicly available.
Can I buy Unravel Health stock?
Unravel Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Unravel Health's last funding round?
Unravel Health's most recent funding round was Pre Seed on October 14, 2026.
Who are the main investors in Unravel Health?
Key investors in Unravel Health include Ascension Ventures.
Will Unravel Health IPO soon?
No public IPO plans have been announced for Unravel Health.
How can I track Unravel Health secondary market activity?
Caplight tracks bids, offers, and trades in Unravel Health's shares on secondary markets.